Literature DB >> 22042377

Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling.

Despina Laimou1, Eliada Lazoura, Anastassios N Troganis, Minos-Timotheos Matsoukas, Spyros N Deraos, Maria Katsara, John Matsoukas, Vasso Apostolopoulos, Theodore V Tselios.   

Abstract

Τwo dimensional nuclear magnetic resonance studies complimented by molecular dynamics simulations were conducted to investigate the conformation of the immunodominant epitope of acetylated myelin basic protein residues 1-11 (Ac-MBP(1-11)) and its altered peptide ligands, mutated at position 4 to an alanine (Ac-MBP(1-11)[4A]) or a tyrosine residue (Ac-MBP(1-11)[4Y]). Conformational analysis of the three analogues indicated that they adopt an extended conformation in DMSO solution as no long distance NOE connectivities were observed and seem to have a similar conformation when bound to the active site of the major histocompatibility complex (MHC II). The interaction of each peptide with MHC class II I-A(u) was further investigated in order to explore the molecular mechanism of experimental autoimmune encephalomyelitis induction/inhibition in mice. The present findings indicate that the Gln(3) residue, which serves as a T-cell receptor (TCR) contact site in the TCR/peptide/I-A(u) complex, has a different orientation in the mutated analogues especially in the Ac-MBP(1-11)[4A] peptide. In particular the side chain of Gln(3) is not solvent exposed as for the native Ac-MBP(1-11) and it is not available for interaction with the TCR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042377     DOI: 10.1007/s10822-011-9481-6

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  36 in total

1.  Theoretical prediction of a peptide binding to major histocompatibility complex II.

Authors:  Sarah Aldulaijan; James A Platts
Journal:  J Mol Graph Model       Date:  2010-06-08       Impact factor: 2.518

2.  Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity.

Authors:  B Metzler; D C Wraith
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

3.  T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.

Authors:  S S Zamvil; D J Mitchell; A C Moore; A J Schwarz; W Stiefel; P A Nelson; J B Rothbard; L Steinman
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

4.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Authors:  D C Wraith; D E Smilek; D J Mitchell; L Steinman; H O McDevitt
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 5.  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.

Authors:  L Steinman
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

6.  Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.

Authors:  T Tselios; I Daliani; S Deraos; S Thymianou; E Matsoukas; A Troganis; I Gerothanassis; A Mouzaki; T Mavromoustakos; L Probert; J Matsoukas
Journal:  Bioorg Med Chem Lett       Date:  2000-12-18       Impact factor: 2.823

7.  Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides.

Authors:  T Tselios; I Daliani; L Probert; S Deraos; E Matsoukas; S Roy; J Pires; G Moore; J Matsoukas
Journal:  Bioorg Med Chem       Date:  2000-08       Impact factor: 3.641

8.  An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction.

Authors:  P J Fairchild; R Wildgoose; E Atherton; S Webb; D C Wraith
Journal:  Int Immunol       Date:  1993-09       Impact factor: 4.823

9.  Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH.

Authors:  K Mason; D W Denney; H M McConnell
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

10.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

Authors:  J Goverman; A Woods; L Larson; L P Weiner; L Hood; D M Zaller
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

View more
  4 in total

1.  Large scale characterization of the LC13 TCR and HLA-B8 structural landscape in reaction to 172 altered peptide ligands: a molecular dynamics simulation study.

Authors:  Bernhard Knapp; James Dunbar; Charlotte M Deane
Journal:  PLoS Comput Biol       Date:  2014-08-07       Impact factor: 4.475

2.  Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP82⁻98) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II.

Authors:  George Deraos; Eftichia Kritsi; Minos-Timotheos Matsoukas; Konstantina Christopoulou; Hubert Kalbacher; Panagiotis Zoumpoulakis; Vasso Apostolopoulos; John Matsoukas
Journal:  Brain Sci       Date:  2018-12-04

3.  How peptide/MHC presence affects the dynamics of the LC13 T-cell receptor.

Authors:  Jose Luis Dominguez; Bernhard Knapp
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

4.  The Long Road of Immunotherapeutics against Multiple Sclerosis.

Authors:  Vasso Apostolopoulos; Abdolmohamad Rostami; John Matsoukas
Journal:  Brain Sci       Date:  2020-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.